HBOT.COM

Giving people back their lives!

The Oxygen Revolution

By Dr. Paul G. Harch
and Virginia McCullough

Read More

WHAT IS HBOT?

Learn what HBOT is all about in this short video.

Video - Hyperbaric Oxygen Therapy (HBOT) is the use of 100% oxygen in a pressurized chamber to treat wounds in the body of any duration in any location.

Learn More

HELP US CHANGE LIVES, DONATE TODAY

HELP SUPPORT US

Make a Difference!

Donate now!

 

The Townsend Letter Includes Hyperbaric Oxygen Therapy

TownsendLetter.com

Oxygen and Pressure Epigenetics: Understanding Hyperbaric Oxygen Therapy After 355 Years as the Oldest Gene Therapy Known to Man

Published in the Townsend Letter April 2018

by Paul G. Harch, MD

 

Despite the “Decade of the Brain” from 1990-20001 and all the advances of modern medicine, treatment of the most common neurological diseases (traumatic brain injury, stroke, and dementia) has made minimal progress in the last 100 years. In 2017 Alzheimer’s Dementia alone accounts for 5.4 million cases in the U.S.  Total costs for dementia are estimated to be $259 million this year.  The numbers will burgeon in the decades ahead as the Baby Boomers’ demographic and the excesses of their earlier years pay a negative dividend.

Intermittent Supplemental Normobaric Oxygen Therapy

More of Dr Harch's work for brain injury recovery: Parents of brain injured babies & children from all over the world are starting with his protocol at home before coming his office for HBOT in New Orleans. Created by Paul G Harch MD - Harch Hyperbarics Inc.
Thanks to Eden Carlson’s social-media presence, info started spreading world wide March 2016

HBOT Treatment for Drug Addiction

Hyperbaric oxygenation in the treatment of patients with drug addiction, narcotic addiction and alcoholism in the post-intoxication and abstinence periods

 

Epifanova NM. Anesteziol Reanimatol. 1995 May-Jun.

 

Authors

Epifanova NM.

Citation

 

Anesteziol Reanimatol. 1995 May-Jun;(3):34-9.

Abstract

 

Hyperbaric oxygenation was used in the treatment of 340 patients with narcomania, toxicomania, and alcoholism in the post-intoxication and abstinence periods; 223 of these were alcoholics, 68 toxicomaniacs, and 49 opium narcomaniacs. A group of 185 patients administered drug therapy alone were controls. Exposure to hyperbaric oxygenation had a favorable effect on the patient's status during sessions and persisted for some time after them. Patients with different premorbid symptoms and initial status experienced tranquilizing or bioenergizing effects of hyperbaric oxygen. A comparative clinical and psychopathological examination of patients in both groups showed accelerated reduction of psychoneurological and somatovegetative disorders, this bringing about an approximately twofold decrease of treatment duration and preventing the development of complications. The parameters of central hemodynamics normalized and myocardial status improved, which helped prevent the development of cardiovascular decompensation. Such a favorable time course of events appears to be due to the antihypoxic detoxifying and bioenergetic effects of hyperbaric oxygen.

 

Hyperbaric Oxygen Therapy Trials focused on PTSD TBI Study

Now open to Marines, sailors aboard Camp Lejeune

By Naomi Whidden
The Daily News - Jacksonville NC

Thanks in part to the efforts of a U.S. congressman, Marines and sailors aboard Camp Lejeune will be eligible to participate in a medical study involving hyperbaric oxygen therapy to treat post-traumatic stress disorder and traumatic brain injury.

Congressman Walter B. Jones has succeeded in advocating for their inclusion in the study that focuses on the use of hyperbaric oxygen therapy. The non-invasive procedure exposes the body to 100-percent oxygen at high pressure . Patients enters a clear chamber for a period of time while the pressure and oxygen levels increase to fill the blood with enough oxygen to repair tissues and restore normal body function, according to Johns Hopkins Medicine website.

The study is conducted by Dr. Paul Harch, the Department of Internal Medicine director at Louisiana State University School of Medicine and a clinical professor.

Pages